Ultomiris Drug Interactions: 219 Major, 38 Moderate
Ultomiris (Ravulizumab) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ultomiris. Always confirm against the full prescribing information.
100 interactions
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Ravulizumab.
Level 2 evidence
AstraZeneca COVID-19 Vaccine
The therapeutic efficacy of AstraZeneca COVID-19 Vaccine can be decreased when used in combination with Ravulizumab.
The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ravulizumab.
The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Ravulizumab.
Level 2 evidence
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Ravulizumab.
Level 1 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Aducanumab.
Level 2 evidence
Alirocumab
The risk or severity of adverse effects can be increased when Alirocumab is combined with Ravulizumab.
Level 2 evidence
Allogeneic processed thymus tissue
The therapeutic efficacy of Allogeneic processed thymus tissue can be decreased when used in combination with Ravulizumab.
Level 2 evidence
Amivantamab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Amivantamab.
Level 2 evidence
Ansuvimab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Ansuvimab.
Level 2 evidence
Anthrax vaccine
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Ravulizumab.
Level 1 evidence
Enter your NPI to unlock 66 major interactions for Ultomiris
Ultomiris (Ravulizumab) has 379 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Ultomiris (Ravulizumab) has 219 major, 38 moderate, and 122 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Ultomiris. Always confirm against the full prescribing information.